Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia

Blood

Volumn 83, Issue 11, 1994, Pages 3409-3416

  Mackinnon, Stephen ^a   Barnett, Lorna ^a   Heller, Glenn ^a   O'Reilly, Richard J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; THIOTEPA;

ARTICLE; BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHIMERA; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOGENETICS; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; WHOLE BODY RADIATION;

EID: 0028206129     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v83.11.3409.3409     Document Type: Article

References (43)

1. Goldman JM, Gale RP, Horowitz MM, Biggs JC, Champlin RE, Gluckman E, Hoffmann RG, Jacobsen SJ, Marmont AM, McGlave PB, Messner HA, Rimm AA, Rozman C, Speck B, Tura S, Weiner RS, Bortin MM: Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: Increased risk of relapse associated with T cell depletion. Ann Intern Med 108:806, 1988
2. Clift RA. Buckner CD, Appelbaum FR, Bryant E, Bearman SI, Petersen FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill RS, McDonald GB, Martin P, Meyers J, Sanders J, Singer J, Stewart P, Sullivan KM, Witherspoon R, Storb R, Hansen JA, Thomas ED: Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens. Blood 77:1990, 1991
3. Apperley JF, Jones L, Hale G. Waldmann H, Hows J, Rombos Y, Tsatalas C, Marcus RE, Goolden AWG. Gordon-Smith EC, Catovsky D, Galton DAG, Goldman JM: Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft versus host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant 1:53, 1986
4. Lawler M, Humphries P, McCann SR: Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood 77:2504, 1991
5. Roy DC, Tantravahi R, Murray C, Dear K, Gorgone B, Anderson KC, Freedman AS, Nadler LM, Ritz J: Natural history of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: A stable equilibrium. Blood 75:296, 1990
6. Bertheas MF, Maraninchi D, Lafage M, Fraisse J, Biaise D, Stoppa AM, Michel G, Brizard CP, Gaspard MH, Novakovitch G, Mannoni P, Viens P, Carcassonne Y: Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: A cytogenetic documentation. Blood 72:89, 1988
7. Schattenberg A, de Witte T, Salden M, Vet J, Van Dijk B, Siiieets D, Hoogenhout J, Haanen C: Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood 73:1367, 1989
8. Petz LD, Yam P, Wallace RB, Stock AD, De Lange G, Knowlton RG, Brown VA, Donis Keller H, Hill LR, Forman SJ, Blume KG: Mixed hematopoietic chimerism following bone marrow transplantation for hematologi malignancies. Blood 70:1331, 1987
9. van Leeuwen JEM, van Tol MDJ, Joosten AM, Wijnen JTh. Meera Khan P, Vossen JM: Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 82:1921, 1993
10. Lawler SD, Harris H, Millar J, Barrett A, Powles RL: Cytogenetic follow-up studies of recipients of T-cell depleted allogeneic bone marrow. Br J Haematol 65:143, 1987
11. Walker H, Singer CRJ, Patterson J: The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants. Br J Haematol 62:385, 1986
12. Offit K, Burns JP, Cunningham I, Jhanwar SC, Black P, Kernan NA, O'Reilly RJ, Chaganti RSK: Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after T cell-depleted bone marrow transplantation. Blood 75:1346, 1990
13. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM: Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood 75:555, 1990
14. Kernan NA, Collins NH, Cunningham I, Castro-Malespina H, Flomenberg N, Gulati S, Brochstein J, Emanuel D, Laver J, Keever CA, Bordignon C, Burns J, Frame J, Small T, Gillio A, Bonilla M. Pecora A, Kushner B, Quijana C, Pelus L, Weite K, O'Reilly RJ: Prevention of GVHD in HLA-identical marrow grafts by removal of T cells with soybean agglutinin and SRBCs. Bone Marrow Transplant 2:13, 1987 (abstr, suppl 1)
15. Collins NH, Gazzola MV, Lebkowski J, Okarma T, O'Reilly RJ: T cell depletion of allogeneic bone marrow grafts by soybean lectin agglutination and adherence on CD5/CD8 Cellector-T cell: Laboratory evaluation. Blood 76:533a, 1990 (abstr, suppl 1)
16. Kawasaki ES: Sample preparation from blood, cells, and other fluid, in Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds): PCR protocols: A Guide to Methods and Applications, San Diego, CA, Academic, 1990, p 146
17. Burns GF, Boyd AW, Beverley PCL: Two monoclonal antihuman T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen. J Immunol 129:1451, 1982
18. Leivestad T, Gaudernack G, Ugelstad J, Thorsby E: Isolation of pure and functionally active T4 and T8 cells by positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. Transplantation Proc 19:265, 1987
19. Li HH, Gyllensten UB, Cui XF, Saiki RK. Erlich HA, Arnheim N: Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature 335:414, 1988
20. Jeffreys AJ, Wilson V, Neumann R, Keyte J: Amplification of human minisatellites by the polymerase chain reaction: Towards DNA fingerprinting of single cells. Nucleic Acids Res 16:10953, 1988
21. Wolff RK, Nakamura Y, White R: Molecular characterization of a spontaneously generated new allele at a VNTR locus: No exchange of flanking DNA sequence. Genomics 3:347, 1988
22. Jarman AP, Nicholls RD, Weatherall DJ, Clegg JB, Higgs DR: Molecular characterisation of a hypervariable region downstream of the human a-globin gene structure. EMBO J 5:1857, 1986
23. Richards B, Heilig R, Oberle I, Storjohann L, Horn GT: Rapid PCR analysis of the St 14 (DXS52) VNTR. Nucleic Acids Res 19:1944, 1991
24. Boerwinkle E, Xiong W, Fourest E, Chan L: Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: Application to the apolipoprotein B 3′ hypervariable region. Proc Natl Acad Sci USA 86:212, 1989
25. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 162:156, 1987
26. Hughes TP, Morgan GJ, Martial P, Goldman JM: Detection of residual leukemia after hone marrow transplant for chronic myeloid leukemia: Role of polymerase chain reaction in predicting relapse. Blood 77:874, 1991
27. Kwok S, Higushi R: Avoiding false positives with PCR. Nature 339:237, 1989
28. Thompson JD, Brodsky I, Yunis JJ: Molecular quantification of residual disease in chronic myelogenous leukemia after bone marrow transplantation. Blood 79:1629, 1991
29. Dunn JJ, Studier FW: Complete nucleotide sequence of bacteriophage T7 DNA and the locations of the T7 genetic elements. J Mol Biol 166:477, 1983
30. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
31. Mackinnon S, Barnett L, Bourhis JH, Black P, Heller G, O'Reilly RJ: Myeloid and lymphoid chimerism following T-cell depleted bone marrow transplantation: Evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood 80:3235, 1992
32. Apperley JF, Mauro F, Goldman JM, Gregory W, Arthur CK, Hows J, Arcese W, Papa G, Mandelli F, Wardle D, Gravett P, Franklin IM, Bandini G, Ricci P, Tura S, Iacone A, Torlontano G, Heit W, Champlin R, Gale RP: Bone marrow transplantation for chronic myeloid leukaemia in chronic phase: Importance of a graft versus leukaemia effect. Br J Haematol 69:239, 1988
33. Kolb HJ, Mittermuller J, Clemm Ch, Holler E, Ledderose G, Brehm G, Heim M, Wilmanns W: Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76:2462, 1990
34. Drobyski WR, Keever CA, Roth MS, Koethe S, Hanson G, McFadden P, Gottschall JL, Ash RC, van Tuinen P, Horowitz MM, Flomenberg N: Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: Efficacy and toxicity of a defined T-cell dose. Blood 82:2310, 1993
35. Weiden PL, Flournoy N, Thomas ED, Prentice R, Fefer A, Buckner CD, Storb R: Antileukemic effect of graft versus host disease in recipients of allogeneic marrow grafts. N Engl J Med 300:1068, 1979
36. Bertheas MF, Lafage M, Levy P, Biaise D, Stoppa AM. Viens P, Mannoni P, Maraninchi D: Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia. Blood 78:3103, 1991
37. Pignon JM, Henni T, Amselem S, Vidaud M, Duquesnoy P, Vernant JP, Kuentz M, Cordonnier C, Rochant H, Goossens M: Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia 4:83, 1990
38. Morgan GJ, Hughes T, Janssen JW, Gow J, Guo AP, Goldman JM, Wiedemann LM, Bartram CR: Polymerase chain reaction for detection of residual leukaemia. Lancet 1:928, 1989
39. Martiat P, Maisin D, Philippe M, Ferrant A, Michaux JL, Cassiman JJ, Van-den-Berghe H, Sokal G: Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers. Br J Haematol 75:355, 1990
40. Roth MS, Antin JH, Bingham EL, Ginsburg D: Use of polymerase chain reaction-detected sequence polymorphisms to document engraftment following allogeneic bone marrow transplantation. Transplantation 49:714, 1990
41. Hughes TP, Goldman JM: Biological importance of residual leukaemic cells after BMT for CML: Does the polymerase chain reaction help? Bone Marrow Transplant 5:3, 1990
42. Roth MS, Antin JH, Ash R, Terry VH, Gotlieb M, Silver SM, Ginsburg D: Prognostic significance of Philadelphia chromosomepositive cells detected by the polymerase chain reaction after allogeneic bone marrow transplant for chronic myelogenous leukemia. Blood 79:276, 1992
43. Cross NCP, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI, Ferrant A, Martial P, Goldman JM: Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukemia in first chronic phase: Correlations with acute graft-versushost disease and relapse. Br J Haematol 84:67, 1993